These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14184304)

  • 1. [IMMEDIATE AND REMOTE RESULTS OF THE TREATMENT OF LYMPHOGRANULOMATOSIS WITH DOPAN].
    IVANOVA EM
    Klin Lech Zlokach Novoobraz; 1963; 91():87-90. PubMed ID: 14184304
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of immediate results in the treatment of lymphogranulomatosis with dopan and degranol].
    RAEVSKII IG
    Vopr Onkol; 1962; 8(4)():3-11. PubMed ID: 14489811
    [No Abstract]   [Full Text] [Related]  

  • 3. DOPAN IN LYMPHOGRANULOMATOSIS. ITS IMMEDIATE AND DISTANT RESULTS.
    IVANOVA EM
    Acta Unio Int Contra Cancrum; 1964; 20():375-6. PubMed ID: 14151933
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of human leukemias and Hodgkin's disease with Dopan (uracil mustard).
    SAMPEY JR
    J S C Med Assoc; 1962 May; 58():175-6. PubMed ID: 14496660
    [No Abstract]   [Full Text] [Related]  

  • 5. [TREATMENT OF LYMPHOGRANULOMATOSIS WITH DOPAN AND DEGRANOL].
    KOLESNIKOV IuP
    Sov Med; 1965 Jan; 28():116-9. PubMed ID: 14307884
    [No Abstract]   [Full Text] [Related]  

  • 6. [A severe case of lymphographylomatosis successfully treated with dopan].
    POSLAVSKII EV; LEKSIKOV IM
    Probl Gematol Pereliv Krovi; 1959 Dec; 4():45-6. PubMed ID: 14434366
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of dopan therapy of lymphogranulomatosis based on the data of the Khirgizin Scientific Research Institute of Oncology and Radiology].
    Sikorskaia IaV
    Sov Zdravookhr Kirg; 1965; 2():34-8. PubMed ID: 4221039
    [No Abstract]   [Full Text] [Related]  

  • 8. [On dopan therapy of patients with lymphogranulomatosis, chronic lymphatic leukemia and other systemic blood diseases].
    PETROV KIa
    Sov Med; 1961 Nov; 25():13-7. PubMed ID: 14485925
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nitrogen mustard therapy of lymphogranulomatosis].
    MOESER H
    Med Klin; 1950 Sep; 45(37):1185-6. PubMed ID: 14785530
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the biological activity of uracil mustard and Dopan.
    PETERING HG; BUSKIRK HH; MUSSER EA; EVANS JS
    Cancer Chemother Rep; 1963 Mar; 27():1-10. PubMed ID: 13942713
    [No Abstract]   [Full Text] [Related]  

  • 11. [Critical observations on the treatment of lymphogranulomatosis with nitrogen mustards].
    PINKER H; BRAUN H
    Arztl Wochensch; 1950 Apr; 5(13-14):207-10. PubMed ID: 15419094
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of sarcolysin and dopan on the biosynthesis of pyrimidines of nucleic acid in transplanted tumors and tissues of the recipient organism].
    DAVYDOVA SIa; SAPOZHNIKOVA MB
    Biull Eksp Biol Med; 1960 Mar; 49():89-93. PubMed ID: 13814551
    [No Abstract]   [Full Text] [Related]  

  • 13. [A CASE OF ACUTE POISONING WITH DOPAN].
    BOGORODSKAIA TA; MIKHAILOVA EN; OGIBINA LN; SHCHERBA MM
    Ter Arkh; 1965 Jan; 37():107-9. PubMed ID: 14342983
    [No Abstract]   [Full Text] [Related]  

  • 14. CLINICAL EVALUATION OF URACIL MUSTARD.
    WILLIAMS HM
    Cancer Chemother Rep; 1963 Oct; 32():73-6. PubMed ID: 14088838
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined chemotherapy with dopan + natulan + vincristine + prednisolone in children with lymphogranulomatosis].
    Durnov LA; Susuleva NA; Lichinitsev MR
    Pediatriia; 1979 Jan; (1):43-7. PubMed ID: 432030
    [No Abstract]   [Full Text] [Related]  

  • 16. [Roentgen resistant lymphogranulomatosis treated with trichlorotriethylamine hydrochloride, with special reference to following modifications in the hemopoietic system].
    TEWES H
    Med Monatsschr; 1950 Jul; 4(7):534-7. PubMed ID: 15438635
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy and limitations of karyoklastic therapy of leukosis, lymphogranulomatosis, and malignant tumors in childhood].
    WEICKER H
    Kinderarztl Prax; 1950; 18():143-50. PubMed ID: 14785133
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological comparisons on a new antitumor agent: dopan].
    MAZZUCCHELLI L
    Boll Chim Farm; 1962 Aug; 101():630-2. PubMed ID: 13934278
    [No Abstract]   [Full Text] [Related]  

  • 19. [SPECTROPHOTOMETRIC DETERMINATION OF CYTOSTATICS FROM THE DICHLOROETHYLAMINE GROUP (DOPAN AND SARCOLYSIN) IN THE ULTRAVIOLET RANGE].
    BLAZHEK IIa; KRACHMAR I
    Farm Zh; 1965; 20():22-5. PubMed ID: 14348007
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quantitative determination of dopan].
    Tret'iakov NA
    Farmatsiia; 1967; 16(6):63-4. PubMed ID: 5612250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.